Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury

Journal of Surgical Research

Volumn 185, Issue 2, 2013, Pages 740-747

  Chen, Qiuhua ^a   Yang, Yi ^a   Huang, Yingzi ^a   Pan, Chun ^a   Liu, Ling ^a   Qiu, Haibo ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Angiotensin II; Angiotensin (1 7); Fibrosis; Mas receptor

Indexed keywords

ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYDROXYPROLINE; LIPOPOLYSACCHARIDE; LOSARTAN; MAS RECEPTOR; RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN I (1 7); ANGIOTENSIN I (1-7); ANGIOTENSIN II; G PROTEIN COUPLED RECEPTOR; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO ONCOGENE PROTEINS C MAS 1; PROTO-ONCOGENE PROTEINS C-MAS-1; VASODILATOR AGENT;

ACUTE LUNG INJURY; AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; INFLAMMATION; INFLAMMATORY CELL; INTRACELLULAR SIGNALING; LUNG ALVEOLUS WALL; LUNG EDEMA; LUNG FIBROSIS; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; THICKNESS; ADULT RESPIRATORY DISTRESS SYNDROME; ANGIOTENSIN-(1-7); ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG ANTAGONISM; FIBROSIS; MAS RECEPTOR; METABOLISM; PATHOLOGY; ANTAGONISTS AND INHIBITORS; PULMONARY FIBROSIS; RESPIRATORY DISTRESS SYNDROME, ADULT;

ACUTE LUNG INJURY; ACUTE RESPIRATORY DISTRESS SYNDROME; ANGIOTENSIN II; ANGIOTENSIN-(1-7); FIBROSIS; MAS RECEPTOR;

ACUTE LUNG INJURY; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; DISEASE MODELS, ANIMAL; LIPOPOLYSACCHARIDES; LOSARTAN; MALE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; PULMONARY FIBROSIS; RECEPTORS, G-PROTEIN-COUPLED; RESPIRATORY DISTRESS SYNDROME, ADULT; VASODILATOR AGENTS;

EID: 84891694690     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.06.052     Document Type: Article

References (30)

1. Phua J, Badia JR, Adhikari NKJ, et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009;179:220.
2. Miwa C, Koyama S, Watanabe Y, et al. Pathological findings and pulmonary dysfunction after acute respiratory distress syndrome for 5 years. Intern Med 2010;49:1599.
3. Marshall RP, Bellingan G, Webb S, et al. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000;162: 1783.
4. Rocco PR, Dos Santos C, Pelosi P. Lung parenchyma remodeling in acute respiratory distress syndrome. Minerva Anestesiol 2009;75:730.
5. Martin C, Papazian L, Payan MJ, Saux P, Gouin F. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome: a study in mechanically ventilated patients. Chest 1995;107:196.
6. Imai Y, Kuba K, Penninger J. The renin-angiotensin system in acute respiratory distress syndrome. Drug Discov Today 2006;3:225.
7. Uhal BD, Li X, Piasecki CC, Molina-Molina M. Angiotensin signalling in pulmonary fibrosis. Int J Biochem Cell Biol 2012; 44:465.
8. Liu L, Qiu HB, Yang Y, Wang L, Ding HM, Li HP. Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat. Arch Biochem Biophys 2009;481:131.
9. Li LF, Liao SK, Huang CC, Hung MJ, Quinn DA. Serine/threonine kinase-protein kinase B and extracellular signal-regulated kinase regulate ventilator-induced pulmonary fibrosis after bleomycin-induced acute lung injury: a prospective, controlled animal experiment. Crit Care 2008; 12:R103.
10. Shenoy V, Ferreira AJ, Qi Y, et al. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 2010; 182:1065.
11. Lubel JS, Herath CB, Tchongue J, et al. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. Clin Sci (Lond) 2009;117: 375.
12. Zhao Y, Gorshkova IA, Berdyshev E, et al. Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression. Am J Respir Cell Mol Biol 2011; 45:426.
13. Hu K, Gaudron P, Anders HJ, et al. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. Cardiovasc Res 1998;39:401.
14. Grobe JL, Mecca AP, Mao H, Katovich MJ. Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol 2006; 290:H2417.
15. Li H, Du S, Yang L, et al. Rapid pulmonary fibrosis induced by acute lung injury via a lipopolysaccharide three-hit regimen. Innate Immun 2009;15:143.
16. Garibaldi BT, D'Alessio FR, Mock JR, et al. Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment. Am J Respir Cell Mol Biol 2013;48:35.
17. Brigham KL, Woolverton WC, Blake LH, Staub NC. Increased sheep lung vascular permeability caused by pseudomonas bacteremia. J Clin Invest 1974;54:792.
18. Smith KM, Mrozek JD, Simonton SC, et al. Prolonged partial liquid ventilation using conventional and high-frequency ventilatory techniques: gas exchange and lung pathology in an animal model of respiratory distress syndrome. Crit Care Med 1997;25:1888.
19. Yoshida K, Kuwano K, Hagimoto N, et al. MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis. J Pathol 2002;198:388.
20. Idell S, Kueppers F, Lippmann M, Rosen H, Niederman M, Fein A. Angiotensin converting enzyme in bronchoalveolar lavage in ARDS. Chest 1987;91:52.
21. Okada M, Suzuki K, Matsumoto M, et al. Effects of angiotensin on the expression of fibrosis-associated cytokines, growth factors, and matrix proteins in human lung fibroblasts. J Clin Pharm Ther 2009;34:288.
22. Papp M, Li X, Zhuang J, Wang R, Uhal BD. Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II. Am J Physiol Lung Cell Mol Physiol 2002;282:L713.
23. Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 2000;161:1999.
24. Yang F, Chung AC, Huang XR, et al. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and-independent Smad pathways: the role of Smad3. Hypertension 2009;54:877.
25. Geirsson A, Singh M, Ali R, et al. Modulation of transforming growth factor-b signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers. Circulation 2012;126:S189.
26. Mercure C, Yogi A, Callera GE, et al. Angiotensin (1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res 2008;103:1319.
27. Santos RA, Castro CH, Gava E, et al. Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor MAS knockout mice. Hypertension 2006;47:996.
28. Uhal BD, Li X, Xue A, Gao X, Abdul-Hafez A. Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis. Am J Physiol Lung Cell Mol Physiol 2011;301: L269.
29. Wösten-van Asperen RM, Lutter R, Specht PA, et al. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J Pathol 2011;225:618.
30. Grobe JL, Mecca AP, Lingis M, et al. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol 2007;292:H736.